Learn more

XUANWU HOSPITAL OF CAPITAL UNI

Overview
  • Total Patents
    13
About

XUANWU HOSPITAL OF CAPITAL UNI has a total of 13 patent applications. Its first patent ever was published in 2002. It filed its patents most often in China. Its main competitors in its focus markets pharmaceuticals and environmental technology are AMYLYX PHARMACEUTICALS INC, MEDOSAN RICERCA SRL and GORDAGEN PHARMACEUTICALS PTY LTD.

Patent filings in countries

World map showing XUANWU HOSPITAL OF CAPITAL UNIs patent filings in countries
# Country Total Patents
#1 China 13

Patent filings per year

Chart showing XUANWU HOSPITAL OF CAPITAL UNIs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Lin Li 3
#2 Tao Luo 2
#3 Hengxi Yu 2
#4 Rong Wang 2
#5 Zhijuan Ji 2
#6 Jianping Jia 2
#7 Wen Wang 2
#8 Shuli Sheng 2
#9 Haifeng Wei 2
#10 Jian Zhang 2

Latest patents

Publication Filing date Title
CN101390779A Preparation method of rat chronic posterior-limb ischemia model
CN101308144A Method for detecting subject humoral disease related protein polymerizing power
CN101564320A Method for establishing multiple sclerosis animal model
CN101215323A Human AD7C-NTP antigen determinant polypeptide, antibody and application thereof in diagnosis kit
CN101336927A Use of morroniside in preventing or treating brain fundamental sickness
CN101322713A Applications of gastrodine in preparing cysteine proteinase-3 active inhibitor
CN101306002A Use of ginsenoside in preparing alpha-secretase activity intensifier
CN101259292A Construction method of tissue engineering blood vessel
CN101244074A Uses of epimedium brevicornum flavone and its active ingredient in preparing medicaments for accelerating neurocyte proliferation and differentiation function
CN101139384A 5-peptide derivative, preparation method and use thereof
CN1840043A Pharmaceutical composition for treating depression, its preparation method and application
CN1664098A Parkin transgenation and the detection method thereof relevant with Parkinson's disease
CN1504188A Use of 5-hydroxymethyl furfural in preparation of medicine and healthcare product for prevention and treatment of degenerative disease of nervous system and cognize hurt